Actipol, eye drops 70 µg/ml 5 ml

Pharmacological action – antioxidant, immunomodulatory, antiviral.

It is an inducer of endogenous interferon, which explains one of the mechanisms of specific antiviral action. It has a radioprotective effect, regulates the water-salt balance, stimulates corneal regeneration processes and has no teratogenic, mutagenic and embryotoxic effect.

When applied topically, para-aminobenzoic acid is quickly absorbed and has a therapeutic effect.

Pharmacokinetics
When applied topically, para-aminobenzoic acid is quickly absorbed and has therapeutic effects.

Indications

Active ingredient

Composition

Eye drops 0.007% clear, colorless.

Associates:

Sodium chloride,

water d/i.

How to take, the dosage

Topically: inject into the conjunctival sac 1-2 drops 3-8 times a day.

After clinical recovery continue instillation 2 drops 3 times a day for 7 days.

Interaction

In combination with modified nucleosides (acyclovir, ganciclovir, fludarabine phosphate, etc.) and antibiotics the therapeutic effect is increased. Do not use simultaneously with sulfonamide drugs (albucid), with Encad when used topically.

Special Instructions

Actipol should not be administered simultaneously with sulfonamide drugs for topical use.

Contraindications

Hypersensitivity to the ingredients of the drug.

Side effects

Rarely, conjunctival hyperemia, local allergic reactions.

Overdose

There is no risk of unwanted side effects if Aktipol is accidentally ingested.

Pregnancy use

Till now there are no data from clinical trials concerning the use of the drug during pregnancy, lactation, and in children. However, the drug can be used if the expected benefits exceed the possible risks.